- Pioneering Regenerative Biotechnology with Exosome Based

Pharmaceutical Platform

The main focusing area we are aiming at is to provide an innovative

proprietary regenerative pharmaceutical platform for irreversible

diseases.  We work closely with medical centers and partner

cooperates to identify important issues should be addressed and solve

them using our technical expertise. ExosomePlus has successfully

demonstrated commercially available high volume exosome isolation

technology and its characterization methodology for quality control of

isolated EVs. We have an exciting pipeline under pre-clinical study that

address significant unmet needs.